EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

Pharma in South Africa, access, pricing and reimbursement

In this episode, GOLD is joined by two international experts in market access, talking about pricing, reimbursement and more in South Africa and Europe.

Learnings from the Next Pharma Summit

In this bonus episode, Helena offers her reflections on the Next Pharma Summit, and Isabel catches up with the event founder Dario Safaric.

Communication, data in R&D and leadership

In this episode, Helena and Marc are joined by Amgen’s Emma Booth to discuss all things R&D, plus medical affairs communication and more.

Mental health: awareness, access and influence in pharma

For this episode, the team is joined by Wendy Bartie, BMS, and Courtney Billington, Janssen Neuroscience, to talk all things mental health: awareness, access and influence in pharma.

Social sustainability, patient advocacy and policy campaigning

In this episode, Marc and Helena are joined by Leo Pharma’s Klaus League to discuss social sustainability, patient advocacy and policy campaigning.

RWE, the metrics of medical affairs and TikTok marketing

Marc and Helena are joined by Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology at AstraZeneca, and many more guests, talking medical affairs, RWE and TikTok marketing.

Driving access to digital, gene therapies and rare disease education

In this episode, Marc and Helena talk about digital access with Alira Health’s Aaron Grandy and about haemophilia with patient advocate Laurence Woollard.

2022 pharma predictions – where are we now?

In this episode, at the season’s half way point, Marc, Helena and Isabel look back at our 2022 predictions for pharma industry – were our guests right?
We’ve noticed you’re accessing
from North/South America.